In contrast with the damage evoked by transient global ischemia, where retinal alterations are not observed at day-250, the I/R model is characterized by a severe and aggressive reduction in retinal thickness and total cell number in the GCL and NeuN+ cells at day-23,51. The gene discussed is RBFOX3; the disease is ischemia.